Location of BRCA1 in human breast and ovarian cancer cells - Response

被引：46
|
作者：
Chen, YM
Chen, PL
Riley, DJ
Lee, WH
Allred, DC
Osborne, CK
机构：
[1] UNIV TEXAS,HLTH SCI CTR,DEPT PATHOL,SAN ANTONIO,TX 78284
[2] UNIV TEXAS,HLTH SCI CTR,DEPT MED,SAN ANTONIO,TX 78284
来源：
SCIENCE | 1996年 / 272卷 / 5258期
关键词：
D O I：
10.1126/science.272.5258.125
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：125 / 126
页数：2
相关论文
共 50 条
  • [31] Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2
    Petrucelli, Nancie
    Daly, Mary B.
    Feldman, Gerald L.
    GENETICS IN MEDICINE, 2010, 12 (05) : 245 - 259
  • [32] Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
    Kuchenbaecker, Karoline B.
    Hopper, John L.
    Barnes, Daniel R.
    Phillips, Kelly-Anne
    Mooij, Thea M.
    Roos-Blom, Marie-Jose
    Jervis, Sarah
    van Leeuwen, Flora E.
    Milne, Roger L.
    Andrieu, Nadine
    Goldgar, David E.
    Terry, Mary Beth
    Rookus, Matti A.
    Easton, Douglas F.
    Antoniou, Antonis C.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (23): : 2402 - 2416
  • [33] BRCA1 mutations in women with double primary breast and ovarian cancer
    Lalloo, F
    Redmond, E
    Wu, CL
    Cochrane, S
    Elles, R
    Evans, DGR
    JOURNAL OF MEDICAL GENETICS, 1999, 36 : S40 - S40
  • [34] BRCA1 screening in patients with a family history of breast or ovarian cancer
    Arver, B
    Claro, A
    Langerod, A
    Borresen-Dale, AL
    Lindblom, A
    GENETIC TESTING, 1999, 3 (02): : 223 - 226
  • [35] GENETIC TESTING IN BREAST OVARIAN-CANCER (BRCA1) FAMILIES
    WATSON, M
    MURDAY, V
    LLOYD, S
    PONDER, B
    AVERILL, D
    EELES, R
    LANCET, 1995, 346 (8974): : 583 - 583
  • [36] BRCA1 polimorphisms in Portuguese breast/ovarian cancer families.
    Brandao, R
    Machao, P
    Povoa, I
    Duarte, I
    Costa, O
    Vaz, F
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 417 - 417
  • [37] Impact of genetic testing in breast/ovarian cancer (BRCA1) families
    Watson, M
    Lloyd, S
    Murday, V
    Ponder, B
    Averill, D
    Eeles, R
    PSYCHO-ONCOLOGY, 1996, 5 (04) : 361 - 361
  • [38] Systemic therapy of BRCA1 and 2 positive breast and ovarian cancer
    Schmutzler, R. K.
    Schott, S.
    GYNAKOLOGE, 2014, 47 (10): : 769 - 772
  • [39] Strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
    Miki, Y.
    Swensen, J.
    Shattuck-Eidens, D.
    Fatreal, P.A.
    Harshman, K.
    Tavtigian, S.
    Liu, Q.
    Cochran, C.
    Bennett, L.M.
    Ding, W.
    Bell, R.
    Science, 1994, 266 (5182)
  • [40] The contribution of founder mutations in BRCA1 to breast and ovarian cancer in Lithuania
    Elsakov, P.
    Kurtinaitis, J.
    Petraitis, S.
    Ostapenko, V.
    Razumas, M.
    Razumas, T.
    Meskauskas, R.
    Petrulis, K.
    Luksite, A.
    Lubinski, J.
    Gorski, B.
    Narod, S. A.
    Gronwald, J.
    CLINICAL GENETICS, 2010, 78 (04) : 373 - 376
12345